[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fUt4-rKNJHFK7CkVqODx52NwPbzKDNTEU-wEsYU1Ny-g":3},{"locale":4,"topic":5,"relatedTrends":74},"en",{"topic":6,"slug":7,"nicheKey":8,"nicheName":9,"nicheNameEn":10,"nicheIcon":11,"country":12,"countries":13,"agentKey":14,"score":15,"type":16,"detectedAt":17,"sources":18,"evidence":71},"OpenAI's scientific drug-discovery AI model for pharma","openai-s-scientific-drug-discovery-ai-model-for-pharma","ia","Intelligence Artificielle","Artificial Intelligence","🧠","NL",[12],"ia-NL",93,"spiking","2026-04-17T04:57:54.329Z",[19,25,31,36,41,46,51,56,61,66],{"title":20,"url":21,"domain":22,"snippet":23,"content":24},"OpenAI Targets Pharma Giants With Purpose-Built AI Model","https:\u002F\u002Fwww.pymnts.com\u002Fartificial-intelligence-2\u002F2026\u002Fopenai-targets-pharma-giants-with-purpose-built-ai-model\u002F","pymnts.com","OpenAI introduced an AI model purpose-built for scientific research and drug discovery.","By|April 16, 2026\n\n|\n\n!\n\n has introduced an artificial intelligence model that is purpose-built for scientific research and drug discovery.\n\nComplete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.\n\n- [x] yes Subscribe to our daily newsletter, PYMNTS Today.\n\nBy completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordan\n\n[Content truncated...]",{"title":26,"url":27,"domain":28,"snippet":29,"content":30},"Introducing GPT-Rosalind for life sciences research","https:\u002F\u002Fopenai.com\u002Findex\u002Fintroducing-gpt-rosalind\u002F","openai.com","Today, we're introducing GPT‑Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine.",null,{"title":32,"url":33,"domain":34,"snippet":35,"content":30},"OpenAI debuts a life sciences AI model, entering crowd of tech giants selling to pharma","https:\u002F\u002Fendpoints.news\u002Fopenai-launches-biopharma-focused-ai-model-to-compete-with-anthropic\u002F","endpoints.news","OpenAI became the latest tech giant to launch a life sciences-focused AI offering, aiming to build a biopharma business.",{"title":37,"url":38,"domain":39,"snippet":40,"content":30},"OpenAI launches drug discovery model, intensifying competition with Google","https:\u002F\u002Funn.ua\u002Fen\u002Fnews\u002Fopenai-launches-drug-discovery-model-intensifying-competition-with-google","unn.ua","УНН Economy ✎ The new AI model GPT-Rosalind will accelerate scientific research for Amgen and Moderna. Shares of biotechnology companies fell amid the...",{"title":42,"url":43,"domain":44,"snippet":45,"content":30},"Novo Nordisk joins forces with OpenAI to fast-track drug research","https:\u002F\u002Fwww.euronews.com\u002Fhealth\u002F2026\u002F04\u002F14\u002Fnovo-nordisk-joins-forces-with-openai-to-fast-track-drug-research","euronews.com","Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug development process.",{"title":47,"url":48,"domain":49,"snippet":50,"content":30},"Novo Nordisk and OpenAI partner to accelerate drug discovery with AI integration","https:\u002F\u002Fmanufacturingchemist.com\u002Fnovo-nordisk-openai-partner-accelerate-drug-discovery-ai","manufacturingchemist.com","The Wegovy and Ozempic maker has struck a strategic deal with OpenAI to embed artificial intelligence across its entire operations, with full integration...",{"title":52,"url":53,"domain":54,"snippet":55,"content":30},"Novo turns to OpenAI to speed drug development","https:\u002F\u002Ffirstwordpharma.com\u002Fstory\u002F7180278","firstwordpharma.com","Novo Nordisk has become the latest drugmaker to partner with AI heavyweight OpenAI in the hopes that the technology will help it bring new and better...",{"title":57,"url":58,"domain":59,"snippet":60,"content":30},"Novo Nordisk partners with OpenAI to AI-power drug development","https:\u002F\u002Fwww.computerweekly.com\u002Fnews\u002F366641591\u002FNovo-Nordisk-partners-with-OpenAI-to-AI-power-drug-development","computerweekly.com","Danish pharmaceutical company Novo Nordisk has partnered with OpenAI to support drug research and development. Through the partnership, Novo Nordisk said it...",{"title":62,"url":63,"domain":64,"snippet":65,"content":30},"Novo Nordisk taps OpenAI to boost AI in drug development","https:\u002F\u002Fwww.tradingview.com\u002Fnews\u002Finvezz:df7d47e48094b:0-novo-nordisk-taps-openai-to-boost-ai-in-drug-development\u002F","tradingview.com","Novo Nordisk on Tuesday announced a partnership with OpenAI to deploy artificial intelligence across its business, spanning drug discovery,...",{"title":67,"url":68,"domain":69,"snippet":70,"content":30},"OpenAI Unveils GPT-Rosalind for Science","https:\u002F\u002Fwww.startuphub.ai\u002Fai-news\u002Fartificial-intelligence\u002F2026\u002Fopenai-unveils-gpt-rosalind-for-science","startuphub.ai","OpenAI launches GPT-Rosalind, a specialized AI model designed to accelerate life sciences research and drug discovery workflows.",{"mentionsLast7Days":72,"mentionsLast30Days":72,"firstSeen":17,"lastSeen":17,"relatedEntities":73},10,[21,27,33,38,43,48,53,58,63,68],[75,79,83,87,92,96],{"topic":76,"slug":77,"score":78,"type":16,"country":12,"nicheIcon":11},"Weekly AI news roundup: April 10, 2026 developments","weekly-ai-news-roundup-april-10-2026-developments",100,{"topic":80,"slug":81,"score":82,"type":16,"country":12,"nicheIcon":11},"Anthropic's updated Opus 4.7 AI model release","anthropic-s-updated-opus-4-7-ai-model-release",96,{"topic":84,"slug":85,"score":86,"type":16,"country":12,"nicheIcon":11},"The AI interpretability problem: opening the black box of models","the-ai-interpretability-problem-opening-the-black-box-of-models",91,{"topic":88,"slug":89,"score":90,"type":91,"country":12,"nicheIcon":11},"Samenwerking Cisco en ML6 voor real-time AI-bescherming","samenwerking-cisco-en-ml6-voor-real-time-ai-bescherming",90,"declining",{"topic":93,"slug":94,"score":95,"type":91,"country":12,"nicheIcon":11},"GPT-5.4-Cyber: OpenAI variant expanding access for security teams","gpt-5-4-cyber-openai-variant-expanding-access-for-security-teams",83,{"topic":97,"slug":98,"score":95,"type":99,"country":12,"nicheIcon":11},"Forbes 2026 AI 50 list of top AI startups","forbes-2026-ai-50-list-of-top-ai-startups","emerging"]